LAST PRICE - AT THE CLOSE
CURE is DOWN -25% since the begininning of the year
CURE is DOWN -6% BELOW 20 day SMA
CURE is DOWN -14% BELOW 200 day SMA
PROFITABLE: N/A
EPS: N/A
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: N/A
 |
THE STOCK IS 44.1% AWAY FROM ALL-TIME HIGHS OF $149.575 |
 |
CURE IS DOWN -25% SINCE THE BEGINNING OF THE YEAR |
 |
CURE IS UP 9% OVER THE PAST 12 MONTHS |
 |
CURE IS DOWN -10% OVER THE PAST 1 MONTH |
 |
N/A% OF ALL CURE INVESTORS ARE BETTING AGAINST CURE |
 |
NUM INVESTORS SHORT CURE HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|---|---|
 | New premarket high. ... | 05/11 |
 | New premarket low. ... | 05/11 |
 | Trading 1% above exp... | 05/11 |
 | Currently at 1 x ave... | 05/11 |
 | Crossed above VWAP | 05/11 |
 |
CURE moved down 0.29 in the previous minute |
 |
CURE is up 0.25 over the last hour |
 |
CURE is up 4.8% over the last 5 days |
 |
CURE is 3.8 above its 8 day SMA |
| $83.13 |   DAY |
$87.17 |
| $84.03 | PREVIOUS DAY |
$86.90 |
| $84.03 | WEEK |
$89.40 |
| $82.41 | MONTH |
$96.78 |
| $66.00 | YEAR |
$123.80 |
CURE is mentioned N/A less than normal on 
CURE is mentioned N/A times in an average day on 
